loading

Inmed Pharmaceuticals Inc Stock (INM) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
5.45%
1.1726
1.2402 0.9019 2.3111 1.0339
Cost Of Revenue
18.45%
0.8831
0.7456 0.7877 1.0085 0.8414
Gross Profit
10.70%
0.2895
0.3241 0.0212 1.5704 0.1925
Operating Expenses
8.36%
2.1338
1.9691 2.6941 2.0866 2.3417
Benefits Costs and Expenses
6.51%
2.8955
2.7184 3.4387 2.6477 3.0304
Costs And Expenses
6.51%
2.8955
2.7184 3.4387 19.77 -2.3417
Depreciation and Amortization
0.85%
0.0548
0.0552 0.0548 0.0535 0.0507
Operating Income/Loss
31.87%
-0.9612
-0.7289 -2.5368 -0.3384 -1.9979
Income/Loss From Continuing Operations Before Tax
16.55%
-1.7229
-1.4782 -2.5368 -0.3366 -1.9964
Income/Loss From Continuing Operations After Tax
16.55%
-1.7229
-1.4782 -2.5368 -0.3497 -1.9964
Net Income/Loss
16.55%
-1.7229
-1.4782 -2.5368 0.30 -1.9979
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - 0.6384 -
Basic Average Shares
20.56%
9.613
7.9735 3.3282 0.2922 3.3282
Diluted Average Shares
20.56%
9.613
7.9735 3.3282 0.2922 3.3282
Basic Earnings Per Share
5.26%
-0.18
-0.19 -0.76 0.28 -0.60
Diluted Earnings Per Share
5.26%
-0.18
-0.19 -0.76 0.28 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):